Market Overview

UPDATE: Biogen Idec Posts Downbeat Q4 Profit, Issues Weak 2013 Profit Forecast

Related BIIB
Citi, Jefferies Weigh In On Biogen Idec Amid Q3 Earnings
US Stock Futures Rise Ahead Of Earnings, Economic Data
Don't Panic Over Recent Tech Turmoil (Fox Business)

Biogen Idec (NASDAQ: BIIB) reported a 2.7% drop in its fourth-quarter earnings.

Biogen expects 2013 adjusted earnings of $7.15 to $7.25 per share on around 10% rise in revenue. However, analysts were expecting a profit of $7.27 per share on 9% revenue growth.

Biogen's quarterly profit fell to $292.1 million, or $1.23 per share, from $300.2 million, or $1.22 per share, in the year-ago period. Excluding one-time items, it earned $1.40 per share.

Its revenue rose 6.9% to $1.42 billion. However, analysts expected earnings of $1.46 per share on revenue of $1.39 billion.

Biogen shares closed at $146.20 on Friday.

Posted-In: profitEarnings News Guidance

 

Related Articles (BIIB)

Around the Web, We're Loving...

Get Benzinga's Newsletters